Global Long-Acting Injectables Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Long-Acting Injectables market size was valued at US$ million in 2023. With growing demand in downstream market, the Long-Acting Injectables is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Long-Acting Injectables market. Long-Acting Injectables are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Long-Acting Injectables. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Long-Acting Injectables market.
Long-acting injectable (LAI) is a kind of pharmaceutical for treating patients with schizophrenia who relapse due to nonadherence to antipsychotic medication. Rather than the daily pill-taking required with oral antipsychotics, LAI antipsychotics are administered by injection at two to four weeks intervals.
Key Features:
The report on Long-Acting Injectables market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Long-Acting Injectables market. It may include historical data, market segmentation by Type (e.g., Small and Middle Sized Molecule, Large Sized Molecule), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Long-Acting Injectables market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Long-Acting Injectables market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Long-Acting Injectables industry. This include advancements in Long-Acting Injectables technology, Long-Acting Injectables new entrants, Long-Acting Injectables new investment, and other innovations that are shaping the future of Long-Acting Injectables.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Long-Acting Injectables market. It includes factors influencing customer ' purchasing decisions, preferences for Long-Acting Injectables product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Long-Acting Injectables market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Long-Acting Injectables market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Long-Acting Injectables market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Long-Acting Injectables industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Long-Acting Injectables market.
Market Segmentation:
Long-Acting Injectables market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Long-Acting Injectables market size was valued at US$ million in 2023. With growing demand in downstream market, the Long-Acting Injectables is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Long-Acting Injectables market. Long-Acting Injectables are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Long-Acting Injectables. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Long-Acting Injectables market.
Long-acting injectable (LAI) is a kind of pharmaceutical for treating patients with schizophrenia who relapse due to nonadherence to antipsychotic medication. Rather than the daily pill-taking required with oral antipsychotics, LAI antipsychotics are administered by injection at two to four weeks intervals.
Key Features:
The report on Long-Acting Injectables market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Long-Acting Injectables market. It may include historical data, market segmentation by Type (e.g., Small and Middle Sized Molecule, Large Sized Molecule), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Long-Acting Injectables market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Long-Acting Injectables market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Long-Acting Injectables industry. This include advancements in Long-Acting Injectables technology, Long-Acting Injectables new entrants, Long-Acting Injectables new investment, and other innovations that are shaping the future of Long-Acting Injectables.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Long-Acting Injectables market. It includes factors influencing customer ' purchasing decisions, preferences for Long-Acting Injectables product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Long-Acting Injectables market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Long-Acting Injectables market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Long-Acting Injectables market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Long-Acting Injectables industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Long-Acting Injectables market.
Market Segmentation:
Long-Acting Injectables market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Small and Middle Sized Molecule
- Large Sized Molecule
- Schizophrenia
- Other Psychotic Disorders
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Eli Lilly
- Pfizer
- GlaxoSmithKline
- Johnson & Johnson
- Lupin
- Zogenix
- DURECT
- Medincel
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Long-Acting Injectables Market Size 2019-2030
2.1.2 Long-Acting Injectables Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Long-Acting Injectables Segment by Type
2.2.1 Small and Middle Sized Molecule
2.2.2 Large Sized Molecule
2.3 Long-Acting Injectables Market Size by Type
2.3.1 Long-Acting Injectables Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Long-Acting Injectables Market Size Market Share by Type (2019-2024)
2.4 Long-Acting Injectables Segment by Application
2.4.1 Schizophrenia
2.4.2 Other Psychotic Disorders
2.5 Long-Acting Injectables Market Size by Application
2.5.1 Long-Acting Injectables Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Long-Acting Injectables Market Size Market Share by Application (2019-2024)
3 LONG-ACTING INJECTABLES MARKET SIZE BY PLAYER
3.1 Long-Acting Injectables Market Size Market Share by Players
3.1.1 Global Long-Acting Injectables Revenue by Players (2019-2024)
3.1.2 Global Long-Acting Injectables Revenue Market Share by Players (2019-2024)
3.2 Global Long-Acting Injectables Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 LONG-ACTING INJECTABLES BY REGIONS
4.1 Long-Acting Injectables Market Size by Regions (2019-2024)
4.2 Americas Long-Acting Injectables Market Size Growth (2019-2024)
4.3 APAC Long-Acting Injectables Market Size Growth (2019-2024)
4.4 Europe Long-Acting Injectables Market Size Growth (2019-2024)
4.5 Middle East & Africa Long-Acting Injectables Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Long-Acting Injectables Market Size by Country (2019-2024)
5.2 Americas Long-Acting Injectables Market Size by Type (2019-2024)
5.3 Americas Long-Acting Injectables Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Long-Acting Injectables Market Size by Region (2019-2024)
6.2 APAC Long-Acting Injectables Market Size by Type (2019-2024)
6.3 APAC Long-Acting Injectables Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Long-Acting Injectables by Country (2019-2024)
7.2 Europe Long-Acting Injectables Market Size by Type (2019-2024)
7.3 Europe Long-Acting Injectables Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Long-Acting Injectables by Region (2019-2024)
8.2 Middle East & Africa Long-Acting Injectables Market Size by Type (2019-2024)
8.3 Middle East & Africa Long-Acting Injectables Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL LONG-ACTING INJECTABLES MARKET FORECAST
10.1 Global Long-Acting Injectables Forecast by Regions (2025-2030)
10.1.1 Global Long-Acting Injectables Forecast by Regions (2025-2030)
10.1.2 Americas Long-Acting Injectables Forecast
10.1.3 APAC Long-Acting Injectables Forecast
10.1.4 Europe Long-Acting Injectables Forecast
10.1.5 Middle East & Africa Long-Acting Injectables Forecast
10.2 Americas Long-Acting Injectables Forecast by Country (2025-2030)
10.2.1 United States Long-Acting Injectables Market Forecast
10.2.2 Canada Long-Acting Injectables Market Forecast
10.2.3 Mexico Long-Acting Injectables Market Forecast
10.2.4 Brazil Long-Acting Injectables Market Forecast
10.3 APAC Long-Acting Injectables Forecast by Region (2025-2030)
10.3.1 China Long-Acting Injectables Market Forecast
10.3.2 Japan Long-Acting Injectables Market Forecast
10.3.3 Korea Long-Acting Injectables Market Forecast
10.3.4 Southeast Asia Long-Acting Injectables Market Forecast
10.3.5 India Long-Acting Injectables Market Forecast
10.3.6 Australia Long-Acting Injectables Market Forecast
10.4 Europe Long-Acting Injectables Forecast by Country (2025-2030)
10.4.1 Germany Long-Acting Injectables Market Forecast
10.4.2 France Long-Acting Injectables Market Forecast
10.4.3 UK Long-Acting Injectables Market Forecast
10.4.4 Italy Long-Acting Injectables Market Forecast
10.4.5 Russia Long-Acting Injectables Market Forecast
10.5 Middle East & Africa Long-Acting Injectables Forecast by Region (2025-2030)
10.5.1 Egypt Long-Acting Injectables Market Forecast
10.5.2 South Africa Long-Acting Injectables Market Forecast
10.5.3 Israel Long-Acting Injectables Market Forecast
10.5.4 Turkey Long-Acting Injectables Market Forecast
10.5.5 GCC Countries Long-Acting Injectables Market Forecast
10.6 Global Long-Acting Injectables Forecast by Type (2025-2030)
10.7 Global Long-Acting Injectables Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Eli Lilly
11.1.1 Eli Lilly Company Information
11.1.2 Eli Lilly Long-Acting Injectables Product Offered
11.1.3 Eli Lilly Long-Acting Injectables Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Eli Lilly Main Business Overview
11.1.5 Eli Lilly Latest Developments
11.2 Pfizer
11.2.1 Pfizer Company Information
11.2.2 Pfizer Long-Acting Injectables Product Offered
11.2.3 Pfizer Long-Acting Injectables Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Pfizer Main Business Overview
11.2.5 Pfizer Latest Developments
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Information
11.3.2 GlaxoSmithKline Long-Acting Injectables Product Offered
11.3.3 GlaxoSmithKline Long-Acting Injectables Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 GlaxoSmithKline Main Business Overview
11.3.5 GlaxoSmithKline Latest Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Information
11.4.2 Johnson & Johnson Long-Acting Injectables Product Offered
11.4.3 Johnson & Johnson Long-Acting Injectables Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Johnson & Johnson Main Business Overview
11.4.5 Johnson & Johnson Latest Developments
11.5 Lupin
11.5.1 Lupin Company Information
11.5.2 Lupin Long-Acting Injectables Product Offered
11.5.3 Lupin Long-Acting Injectables Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Lupin Main Business Overview
11.5.5 Lupin Latest Developments
11.6 Zogenix
11.6.1 Zogenix Company Information
11.6.2 Zogenix Long-Acting Injectables Product Offered
11.6.3 Zogenix Long-Acting Injectables Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Zogenix Main Business Overview
11.6.5 Zogenix Latest Developments
11.7 DURECT
11.7.1 DURECT Company Information
11.7.2 DURECT Long-Acting Injectables Product Offered
11.7.3 DURECT Long-Acting Injectables Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 DURECT Main Business Overview
11.7.5 DURECT Latest Developments
11.8 Medincel
11.8.1 Medincel Company Information
11.8.2 Medincel Long-Acting Injectables Product Offered
11.8.3 Medincel Long-Acting Injectables Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Medincel Main Business Overview
11.8.5 Medincel Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Long-Acting Injectables Market Size 2019-2030
2.1.2 Long-Acting Injectables Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Long-Acting Injectables Segment by Type
2.2.1 Small and Middle Sized Molecule
2.2.2 Large Sized Molecule
2.3 Long-Acting Injectables Market Size by Type
2.3.1 Long-Acting Injectables Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Long-Acting Injectables Market Size Market Share by Type (2019-2024)
2.4 Long-Acting Injectables Segment by Application
2.4.1 Schizophrenia
2.4.2 Other Psychotic Disorders
2.5 Long-Acting Injectables Market Size by Application
2.5.1 Long-Acting Injectables Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Long-Acting Injectables Market Size Market Share by Application (2019-2024)
3 LONG-ACTING INJECTABLES MARKET SIZE BY PLAYER
3.1 Long-Acting Injectables Market Size Market Share by Players
3.1.1 Global Long-Acting Injectables Revenue by Players (2019-2024)
3.1.2 Global Long-Acting Injectables Revenue Market Share by Players (2019-2024)
3.2 Global Long-Acting Injectables Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 LONG-ACTING INJECTABLES BY REGIONS
4.1 Long-Acting Injectables Market Size by Regions (2019-2024)
4.2 Americas Long-Acting Injectables Market Size Growth (2019-2024)
4.3 APAC Long-Acting Injectables Market Size Growth (2019-2024)
4.4 Europe Long-Acting Injectables Market Size Growth (2019-2024)
4.5 Middle East & Africa Long-Acting Injectables Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Long-Acting Injectables Market Size by Country (2019-2024)
5.2 Americas Long-Acting Injectables Market Size by Type (2019-2024)
5.3 Americas Long-Acting Injectables Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Long-Acting Injectables Market Size by Region (2019-2024)
6.2 APAC Long-Acting Injectables Market Size by Type (2019-2024)
6.3 APAC Long-Acting Injectables Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Long-Acting Injectables by Country (2019-2024)
7.2 Europe Long-Acting Injectables Market Size by Type (2019-2024)
7.3 Europe Long-Acting Injectables Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Long-Acting Injectables by Region (2019-2024)
8.2 Middle East & Africa Long-Acting Injectables Market Size by Type (2019-2024)
8.3 Middle East & Africa Long-Acting Injectables Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL LONG-ACTING INJECTABLES MARKET FORECAST
10.1 Global Long-Acting Injectables Forecast by Regions (2025-2030)
10.1.1 Global Long-Acting Injectables Forecast by Regions (2025-2030)
10.1.2 Americas Long-Acting Injectables Forecast
10.1.3 APAC Long-Acting Injectables Forecast
10.1.4 Europe Long-Acting Injectables Forecast
10.1.5 Middle East & Africa Long-Acting Injectables Forecast
10.2 Americas Long-Acting Injectables Forecast by Country (2025-2030)
10.2.1 United States Long-Acting Injectables Market Forecast
10.2.2 Canada Long-Acting Injectables Market Forecast
10.2.3 Mexico Long-Acting Injectables Market Forecast
10.2.4 Brazil Long-Acting Injectables Market Forecast
10.3 APAC Long-Acting Injectables Forecast by Region (2025-2030)
10.3.1 China Long-Acting Injectables Market Forecast
10.3.2 Japan Long-Acting Injectables Market Forecast
10.3.3 Korea Long-Acting Injectables Market Forecast
10.3.4 Southeast Asia Long-Acting Injectables Market Forecast
10.3.5 India Long-Acting Injectables Market Forecast
10.3.6 Australia Long-Acting Injectables Market Forecast
10.4 Europe Long-Acting Injectables Forecast by Country (2025-2030)
10.4.1 Germany Long-Acting Injectables Market Forecast
10.4.2 France Long-Acting Injectables Market Forecast
10.4.3 UK Long-Acting Injectables Market Forecast
10.4.4 Italy Long-Acting Injectables Market Forecast
10.4.5 Russia Long-Acting Injectables Market Forecast
10.5 Middle East & Africa Long-Acting Injectables Forecast by Region (2025-2030)
10.5.1 Egypt Long-Acting Injectables Market Forecast
10.5.2 South Africa Long-Acting Injectables Market Forecast
10.5.3 Israel Long-Acting Injectables Market Forecast
10.5.4 Turkey Long-Acting Injectables Market Forecast
10.5.5 GCC Countries Long-Acting Injectables Market Forecast
10.6 Global Long-Acting Injectables Forecast by Type (2025-2030)
10.7 Global Long-Acting Injectables Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Eli Lilly
11.1.1 Eli Lilly Company Information
11.1.2 Eli Lilly Long-Acting Injectables Product Offered
11.1.3 Eli Lilly Long-Acting Injectables Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Eli Lilly Main Business Overview
11.1.5 Eli Lilly Latest Developments
11.2 Pfizer
11.2.1 Pfizer Company Information
11.2.2 Pfizer Long-Acting Injectables Product Offered
11.2.3 Pfizer Long-Acting Injectables Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Pfizer Main Business Overview
11.2.5 Pfizer Latest Developments
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Information
11.3.2 GlaxoSmithKline Long-Acting Injectables Product Offered
11.3.3 GlaxoSmithKline Long-Acting Injectables Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 GlaxoSmithKline Main Business Overview
11.3.5 GlaxoSmithKline Latest Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Information
11.4.2 Johnson & Johnson Long-Acting Injectables Product Offered
11.4.3 Johnson & Johnson Long-Acting Injectables Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Johnson & Johnson Main Business Overview
11.4.5 Johnson & Johnson Latest Developments
11.5 Lupin
11.5.1 Lupin Company Information
11.5.2 Lupin Long-Acting Injectables Product Offered
11.5.3 Lupin Long-Acting Injectables Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Lupin Main Business Overview
11.5.5 Lupin Latest Developments
11.6 Zogenix
11.6.1 Zogenix Company Information
11.6.2 Zogenix Long-Acting Injectables Product Offered
11.6.3 Zogenix Long-Acting Injectables Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Zogenix Main Business Overview
11.6.5 Zogenix Latest Developments
11.7 DURECT
11.7.1 DURECT Company Information
11.7.2 DURECT Long-Acting Injectables Product Offered
11.7.3 DURECT Long-Acting Injectables Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 DURECT Main Business Overview
11.7.5 DURECT Latest Developments
11.8 Medincel
11.8.1 Medincel Company Information
11.8.2 Medincel Long-Acting Injectables Product Offered
11.8.3 Medincel Long-Acting Injectables Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Medincel Main Business Overview
11.8.5 Medincel Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Long-Acting Injectables Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Small and Middle Sized Molecule
Table 3. Major Players of Large Sized Molecule
Table 4. Long-Acting Injectables Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Long-Acting Injectables Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Long-Acting Injectables Market Size Market Share by Type (2019-2024)
Table 7. Long-Acting Injectables Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Long-Acting Injectables Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Long-Acting Injectables Market Size Market Share by Application (2019-2024)
Table 10. Global Long-Acting Injectables Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Long-Acting Injectables Revenue Market Share by Player (2019-2024)
Table 12. Long-Acting Injectables Key Players Head office and Products Offered
Table 13. Long-Acting Injectables Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Long-Acting Injectables Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Long-Acting Injectables Market Size Market Share by Regions (2019-2024)
Table 18. Global Long-Acting Injectables Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Long-Acting Injectables Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Long-Acting Injectables Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Long-Acting Injectables Market Size Market Share by Country (2019-2024)
Table 22. Americas Long-Acting Injectables Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Long-Acting Injectables Market Size Market Share by Type (2019-2024)
Table 24. Americas Long-Acting Injectables Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Long-Acting Injectables Market Size Market Share by Application (2019-2024)
Table 26. APAC Long-Acting Injectables Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Long-Acting Injectables Market Size Market Share by Region (2019-2024)
Table 28. APAC Long-Acting Injectables Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Long-Acting Injectables Market Size Market Share by Type (2019-2024)
Table 30. APAC Long-Acting Injectables Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Long-Acting Injectables Market Size Market Share by Application (2019-2024)
Table 32. Europe Long-Acting Injectables Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Long-Acting Injectables Market Size Market Share by Country (2019-2024)
Table 34. Europe Long-Acting Injectables Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Long-Acting Injectables Market Size Market Share by Type (2019-2024)
Table 36. Europe Long-Acting Injectables Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Long-Acting Injectables Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Long-Acting Injectables Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Long-Acting Injectables Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Long-Acting Injectables Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Long-Acting Injectables Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Long-Acting Injectables Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Long-Acting Injectables Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Long-Acting Injectables
Table 45. Key Market Challenges & Risks of Long-Acting Injectables
Table 46. Key Industry Trends of Long-Acting Injectables
Table 47. Global Long-Acting Injectables Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Long-Acting Injectables Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Long-Acting Injectables Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Long-Acting Injectables Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Eli Lilly Details, Company Type, Long-Acting Injectables Area Served and Its Competitors
Table 52. Eli Lilly Long-Acting Injectables Product Offered
Table 53. Eli Lilly Long-Acting Injectables Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Eli Lilly Main Business
Table 55. Eli Lilly Latest Developments
Table 56. Pfizer Details, Company Type, Long-Acting Injectables Area Served and Its Competitors
Table 57. Pfizer Long-Acting Injectables Product Offered
Table 58. Pfizer Main Business
Table 59. Pfizer Long-Acting Injectables Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Pfizer Latest Developments
Table 61. GlaxoSmithKline Details, Company Type, Long-Acting Injectables Area Served and Its Competitors
Table 62. GlaxoSmithKline Long-Acting Injectables Product Offered
Table 63. GlaxoSmithKline Main Business
Table 64. GlaxoSmithKline Long-Acting Injectables Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. GlaxoSmithKline Latest Developments
Table 66. Johnson & Johnson Details, Company Type, Long-Acting Injectables Area Served and Its Competitors
Table 67. Johnson & Johnson Long-Acting Injectables Product Offered
Table 68. Johnson & Johnson Main Business
Table 69. Johnson & Johnson Long-Acting Injectables Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Johnson & Johnson Latest Developments
Table 71. Lupin Details, Company Type, Long-Acting Injectables Area Served and Its Competitors
Table 72. Lupin Long-Acting Injectables Product Offered
Table 73. Lupin Main Business
Table 74. Lupin Long-Acting Injectables Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Lupin Latest Developments
Table 76. Zogenix Details, Company Type, Long-Acting Injectables Area Served and Its Competitors
Table 77. Zogenix Long-Acting Injectables Product Offered
Table 78. Zogenix Main Business
Table 79. Zogenix Long-Acting Injectables Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Zogenix Latest Developments
Table 81. DURECT Details, Company Type, Long-Acting Injectables Area Served and Its Competitors
Table 82. DURECT Long-Acting Injectables Product Offered
Table 83. DURECT Main Business
Table 84. DURECT Long-Acting Injectables Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. DURECT Latest Developments
Table 86. Medincel Details, Company Type, Long-Acting Injectables Area Served and Its Competitors
Table 87. Medincel Long-Acting Injectables Product Offered
Table 88. Medincel Main Business
Table 89. Medincel Long-Acting Injectables Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Medincel Latest Developments
Table 1. Long-Acting Injectables Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Small and Middle Sized Molecule
Table 3. Major Players of Large Sized Molecule
Table 4. Long-Acting Injectables Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Long-Acting Injectables Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Long-Acting Injectables Market Size Market Share by Type (2019-2024)
Table 7. Long-Acting Injectables Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Long-Acting Injectables Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Long-Acting Injectables Market Size Market Share by Application (2019-2024)
Table 10. Global Long-Acting Injectables Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Long-Acting Injectables Revenue Market Share by Player (2019-2024)
Table 12. Long-Acting Injectables Key Players Head office and Products Offered
Table 13. Long-Acting Injectables Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Long-Acting Injectables Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Long-Acting Injectables Market Size Market Share by Regions (2019-2024)
Table 18. Global Long-Acting Injectables Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Long-Acting Injectables Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Long-Acting Injectables Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Long-Acting Injectables Market Size Market Share by Country (2019-2024)
Table 22. Americas Long-Acting Injectables Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Long-Acting Injectables Market Size Market Share by Type (2019-2024)
Table 24. Americas Long-Acting Injectables Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Long-Acting Injectables Market Size Market Share by Application (2019-2024)
Table 26. APAC Long-Acting Injectables Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Long-Acting Injectables Market Size Market Share by Region (2019-2024)
Table 28. APAC Long-Acting Injectables Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Long-Acting Injectables Market Size Market Share by Type (2019-2024)
Table 30. APAC Long-Acting Injectables Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Long-Acting Injectables Market Size Market Share by Application (2019-2024)
Table 32. Europe Long-Acting Injectables Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Long-Acting Injectables Market Size Market Share by Country (2019-2024)
Table 34. Europe Long-Acting Injectables Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Long-Acting Injectables Market Size Market Share by Type (2019-2024)
Table 36. Europe Long-Acting Injectables Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Long-Acting Injectables Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Long-Acting Injectables Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Long-Acting Injectables Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Long-Acting Injectables Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Long-Acting Injectables Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Long-Acting Injectables Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Long-Acting Injectables Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Long-Acting Injectables
Table 45. Key Market Challenges & Risks of Long-Acting Injectables
Table 46. Key Industry Trends of Long-Acting Injectables
Table 47. Global Long-Acting Injectables Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Long-Acting Injectables Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Long-Acting Injectables Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Long-Acting Injectables Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Eli Lilly Details, Company Type, Long-Acting Injectables Area Served and Its Competitors
Table 52. Eli Lilly Long-Acting Injectables Product Offered
Table 53. Eli Lilly Long-Acting Injectables Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Eli Lilly Main Business
Table 55. Eli Lilly Latest Developments
Table 56. Pfizer Details, Company Type, Long-Acting Injectables Area Served and Its Competitors
Table 57. Pfizer Long-Acting Injectables Product Offered
Table 58. Pfizer Main Business
Table 59. Pfizer Long-Acting Injectables Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Pfizer Latest Developments
Table 61. GlaxoSmithKline Details, Company Type, Long-Acting Injectables Area Served and Its Competitors
Table 62. GlaxoSmithKline Long-Acting Injectables Product Offered
Table 63. GlaxoSmithKline Main Business
Table 64. GlaxoSmithKline Long-Acting Injectables Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. GlaxoSmithKline Latest Developments
Table 66. Johnson & Johnson Details, Company Type, Long-Acting Injectables Area Served and Its Competitors
Table 67. Johnson & Johnson Long-Acting Injectables Product Offered
Table 68. Johnson & Johnson Main Business
Table 69. Johnson & Johnson Long-Acting Injectables Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Johnson & Johnson Latest Developments
Table 71. Lupin Details, Company Type, Long-Acting Injectables Area Served and Its Competitors
Table 72. Lupin Long-Acting Injectables Product Offered
Table 73. Lupin Main Business
Table 74. Lupin Long-Acting Injectables Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Lupin Latest Developments
Table 76. Zogenix Details, Company Type, Long-Acting Injectables Area Served and Its Competitors
Table 77. Zogenix Long-Acting Injectables Product Offered
Table 78. Zogenix Main Business
Table 79. Zogenix Long-Acting Injectables Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Zogenix Latest Developments
Table 81. DURECT Details, Company Type, Long-Acting Injectables Area Served and Its Competitors
Table 82. DURECT Long-Acting Injectables Product Offered
Table 83. DURECT Main Business
Table 84. DURECT Long-Acting Injectables Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. DURECT Latest Developments
Table 86. Medincel Details, Company Type, Long-Acting Injectables Area Served and Its Competitors
Table 87. Medincel Long-Acting Injectables Product Offered
Table 88. Medincel Main Business
Table 89. Medincel Long-Acting Injectables Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Medincel Latest Developments
LIST OF FIGURES
Figure 1. Long-Acting Injectables Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Long-Acting Injectables Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Long-Acting Injectables Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Long-Acting Injectables Sales Market Share by Country/Region (2023)
Figure 8. Long-Acting Injectables Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Long-Acting Injectables Market Size Market Share by Type in 2023
Figure 10. Long-Acting Injectables in Schizophrenia
Figure 11. Global Long-Acting Injectables Market: Schizophrenia (2019-2024) & ($ Millions)
Figure 12. Long-Acting Injectables in Other Psychotic Disorders
Figure 13. Global Long-Acting Injectables Market: Other Psychotic Disorders (2019-2024) & ($ Millions)
Figure 14. Global Long-Acting Injectables Market Size Market Share by Application in 2023
Figure 15. Global Long-Acting Injectables Revenue Market Share by Player in 2023
Figure 16. Global Long-Acting Injectables Market Size Market Share by Regions (2019-2024)
Figure 17. Americas Long-Acting Injectables Market Size 2019-2024 ($ Millions)
Figure 18. APAC Long-Acting Injectables Market Size 2019-2024 ($ Millions)
Figure 19. Europe Long-Acting Injectables Market Size 2019-2024 ($ Millions)
Figure 20. Middle East & Africa Long-Acting Injectables Market Size 2019-2024 ($ Millions)
Figure 21. Americas Long-Acting Injectables Value Market Share by Country in 2023
Figure 22. United States Long-Acting Injectables Market Size Growth 2019-2024 ($ Millions)
Figure 23. Canada Long-Acting Injectables Market Size Growth 2019-2024 ($ Millions)
Figure 24. Mexico Long-Acting Injectables Market Size Growth 2019-2024 ($ Millions)
Figure 25. Brazil Long-Acting Injectables Market Size Growth 2019-2024 ($ Millions)
Figure 26. APAC Long-Acting Injectables Market Size Market Share by Region in 2023
Figure 27. APAC Long-Acting Injectables Market Size Market Share by Type in 2023
Figure 28. APAC Long-Acting Injectables Market Size Market Share by Application in 2023
Figure 29. China Long-Acting Injectables Market Size Growth 2019-2024 ($ Millions)
Figure 30. Japan Long-Acting Injectables Market Size Growth 2019-2024 ($ Millions)
Figure 31. Korea Long-Acting Injectables Market Size Growth 2019-2024 ($ Millions)
Figure 32. Southeast Asia Long-Acting Injectables Market Size Growth 2019-2024 ($ Millions)
Figure 33. India Long-Acting Injectables Market Size Growth 2019-2024 ($ Millions)
Figure 34. Australia Long-Acting Injectables Market Size Growth 2019-2024 ($ Millions)
Figure 35. Europe Long-Acting Injectables Market Size Market Share by Country in 2023
Figure 36. Europe Long-Acting Injectables Market Size Market Share by Type (2019-2024)
Figure 37. Europe Long-Acting Injectables Market Size Market Share by Application (2019-2024)
Figure 38. Germany Long-Acting Injectables Market Size Growth 2019-2024 ($ Millions)
Figure 39. France Long-Acting Injectables Market Size Growth 2019-2024 ($ Millions)
Figure 40. UK Long-Acting Injectables Market Size Growth 2019-2024 ($ Millions)
Figure 41. Italy Long-Acting Injectables Market Size Growth 2019-2024 ($ Millions)
Figure 42. Russia Long-Acting Injectables Market Size Growth 2019-2024 ($ Millions)
Figure 43. Middle East & Africa Long-Acting Injectables Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa Long-Acting Injectables Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa Long-Acting Injectables Market Size Market Share by Application (2019-2024)
Figure 46. Egypt Long-Acting Injectables Market Size Growth 2019-2024 ($ Millions)
Figure 47. South Africa Long-Acting Injectables Market Size Growth 2019-2024 ($ Millions)
Figure 48. Israel Long-Acting Injectables Market Size Growth 2019-2024 ($ Millions)
Figure 49. Turkey Long-Acting Injectables Market Size Growth 2019-2024 ($ Millions)
Figure 50. GCC Country Long-Acting Injectables Market Size Growth 2019-2024 ($ Millions)
Figure 51. Americas Long-Acting Injectables Market Size 2025-2030 ($ Millions)
Figure 52. APAC Long-Acting Injectables Market Size 2025-2030 ($ Millions)
Figure 53. Europe Long-Acting Injectables Market Size 2025-2030 ($ Millions)
Figure 54. Middle East & Africa Long-Acting Injectables Market Size 2025-2030 ($ Millions)
Figure 55. United States Long-Acting Injectables Market Size 2025-2030 ($ Millions)
Figure 56. Canada Long-Acting Injectables Market Size 2025-2030 ($ Millions)
Figure 57. Mexico Long-Acting Injectables Market Size 2025-2030 ($ Millions)
Figure 58. Brazil Long-Acting Injectables Market Size 2025-2030 ($ Millions)
Figure 59. China Long-Acting Injectables Market Size 2025-2030 ($ Millions)
Figure 60. Japan Long-Acting Injectables Market Size 2025-2030 ($ Millions)
Figure 61. Korea Long-Acting Injectables Market Size 2025-2030 ($ Millions)
Figure 62. Southeast Asia Long-Acting Injectables Market Size 2025-2030 ($ Millions)
Figure 63. India Long-Acting Injectables Market Size 2025-2030 ($ Millions)
Figure 64. Australia Long-Acting Injectables Market Size 2025-2030 ($ Millions)
Figure 65. Germany Long-Acting Injectables Market Size 2025-2030 ($ Millions)
Figure 66. France Long-Acting Injectables Market Size 2025-2030 ($ Millions)
Figure 67. UK Long-Acting Injectables Market Size 2025-2030 ($ Millions)
Figure 68. Italy Long-Acting Injectables Market Size 2025-2030 ($ Millions)
Figure 69. Russia Long-Acting Injectables Market Size 2025-2030 ($ Millions)
Figure 70. Spain Long-Acting Injectables Market Size 2025-2030 ($ Millions)
Figure 71. Egypt Long-Acting Injectables Market Size 2025-2030 ($ Millions)
Figure 72. South Africa Long-Acting Injectables Market Size 2025-2030 ($ Millions)
Figure 73. Israel Long-Acting Injectables Market Size 2025-2030 ($ Millions)
Figure 74. Turkey Long-Acting Injectables Market Size 2025-2030 ($ Millions)
Figure 75. GCC Countries Long-Acting Injectables Market Size 2025-2030 ($ Millions)
Figure 76. Global Long-Acting Injectables Market Size Market Share Forecast by Type (2025-2030)
Figure 77. Global Long-Acting Injectables Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Long-Acting Injectables Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Long-Acting Injectables Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Long-Acting Injectables Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Long-Acting Injectables Sales Market Share by Country/Region (2023)
Figure 8. Long-Acting Injectables Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Long-Acting Injectables Market Size Market Share by Type in 2023
Figure 10. Long-Acting Injectables in Schizophrenia
Figure 11. Global Long-Acting Injectables Market: Schizophrenia (2019-2024) & ($ Millions)
Figure 12. Long-Acting Injectables in Other Psychotic Disorders
Figure 13. Global Long-Acting Injectables Market: Other Psychotic Disorders (2019-2024) & ($ Millions)
Figure 14. Global Long-Acting Injectables Market Size Market Share by Application in 2023
Figure 15. Global Long-Acting Injectables Revenue Market Share by Player in 2023
Figure 16. Global Long-Acting Injectables Market Size Market Share by Regions (2019-2024)
Figure 17. Americas Long-Acting Injectables Market Size 2019-2024 ($ Millions)
Figure 18. APAC Long-Acting Injectables Market Size 2019-2024 ($ Millions)
Figure 19. Europe Long-Acting Injectables Market Size 2019-2024 ($ Millions)
Figure 20. Middle East & Africa Long-Acting Injectables Market Size 2019-2024 ($ Millions)
Figure 21. Americas Long-Acting Injectables Value Market Share by Country in 2023
Figure 22. United States Long-Acting Injectables Market Size Growth 2019-2024 ($ Millions)
Figure 23. Canada Long-Acting Injectables Market Size Growth 2019-2024 ($ Millions)
Figure 24. Mexico Long-Acting Injectables Market Size Growth 2019-2024 ($ Millions)
Figure 25. Brazil Long-Acting Injectables Market Size Growth 2019-2024 ($ Millions)
Figure 26. APAC Long-Acting Injectables Market Size Market Share by Region in 2023
Figure 27. APAC Long-Acting Injectables Market Size Market Share by Type in 2023
Figure 28. APAC Long-Acting Injectables Market Size Market Share by Application in 2023
Figure 29. China Long-Acting Injectables Market Size Growth 2019-2024 ($ Millions)
Figure 30. Japan Long-Acting Injectables Market Size Growth 2019-2024 ($ Millions)
Figure 31. Korea Long-Acting Injectables Market Size Growth 2019-2024 ($ Millions)
Figure 32. Southeast Asia Long-Acting Injectables Market Size Growth 2019-2024 ($ Millions)
Figure 33. India Long-Acting Injectables Market Size Growth 2019-2024 ($ Millions)
Figure 34. Australia Long-Acting Injectables Market Size Growth 2019-2024 ($ Millions)
Figure 35. Europe Long-Acting Injectables Market Size Market Share by Country in 2023
Figure 36. Europe Long-Acting Injectables Market Size Market Share by Type (2019-2024)
Figure 37. Europe Long-Acting Injectables Market Size Market Share by Application (2019-2024)
Figure 38. Germany Long-Acting Injectables Market Size Growth 2019-2024 ($ Millions)
Figure 39. France Long-Acting Injectables Market Size Growth 2019-2024 ($ Millions)
Figure 40. UK Long-Acting Injectables Market Size Growth 2019-2024 ($ Millions)
Figure 41. Italy Long-Acting Injectables Market Size Growth 2019-2024 ($ Millions)
Figure 42. Russia Long-Acting Injectables Market Size Growth 2019-2024 ($ Millions)
Figure 43. Middle East & Africa Long-Acting Injectables Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa Long-Acting Injectables Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa Long-Acting Injectables Market Size Market Share by Application (2019-2024)
Figure 46. Egypt Long-Acting Injectables Market Size Growth 2019-2024 ($ Millions)
Figure 47. South Africa Long-Acting Injectables Market Size Growth 2019-2024 ($ Millions)
Figure 48. Israel Long-Acting Injectables Market Size Growth 2019-2024 ($ Millions)
Figure 49. Turkey Long-Acting Injectables Market Size Growth 2019-2024 ($ Millions)
Figure 50. GCC Country Long-Acting Injectables Market Size Growth 2019-2024 ($ Millions)
Figure 51. Americas Long-Acting Injectables Market Size 2025-2030 ($ Millions)
Figure 52. APAC Long-Acting Injectables Market Size 2025-2030 ($ Millions)
Figure 53. Europe Long-Acting Injectables Market Size 2025-2030 ($ Millions)
Figure 54. Middle East & Africa Long-Acting Injectables Market Size 2025-2030 ($ Millions)
Figure 55. United States Long-Acting Injectables Market Size 2025-2030 ($ Millions)
Figure 56. Canada Long-Acting Injectables Market Size 2025-2030 ($ Millions)
Figure 57. Mexico Long-Acting Injectables Market Size 2025-2030 ($ Millions)
Figure 58. Brazil Long-Acting Injectables Market Size 2025-2030 ($ Millions)
Figure 59. China Long-Acting Injectables Market Size 2025-2030 ($ Millions)
Figure 60. Japan Long-Acting Injectables Market Size 2025-2030 ($ Millions)
Figure 61. Korea Long-Acting Injectables Market Size 2025-2030 ($ Millions)
Figure 62. Southeast Asia Long-Acting Injectables Market Size 2025-2030 ($ Millions)
Figure 63. India Long-Acting Injectables Market Size 2025-2030 ($ Millions)
Figure 64. Australia Long-Acting Injectables Market Size 2025-2030 ($ Millions)
Figure 65. Germany Long-Acting Injectables Market Size 2025-2030 ($ Millions)
Figure 66. France Long-Acting Injectables Market Size 2025-2030 ($ Millions)
Figure 67. UK Long-Acting Injectables Market Size 2025-2030 ($ Millions)
Figure 68. Italy Long-Acting Injectables Market Size 2025-2030 ($ Millions)
Figure 69. Russia Long-Acting Injectables Market Size 2025-2030 ($ Millions)
Figure 70. Spain Long-Acting Injectables Market Size 2025-2030 ($ Millions)
Figure 71. Egypt Long-Acting Injectables Market Size 2025-2030 ($ Millions)
Figure 72. South Africa Long-Acting Injectables Market Size 2025-2030 ($ Millions)
Figure 73. Israel Long-Acting Injectables Market Size 2025-2030 ($ Millions)
Figure 74. Turkey Long-Acting Injectables Market Size 2025-2030 ($ Millions)
Figure 75. GCC Countries Long-Acting Injectables Market Size 2025-2030 ($ Millions)
Figure 76. Global Long-Acting Injectables Market Size Market Share Forecast by Type (2025-2030)
Figure 77. Global Long-Acting Injectables Market Size Market Share Forecast by Application (2025-2030)
